Pharmaceutical Executive October 15, 2021
Jerry V. Gross

Access to quality healthcare and medication is perhaps the most important human need that we face today. However, that’s easier said than done. While strides have been made to better connect consumers with pharma providers, it wasn’t until the COVID-19 pandemic that the industry sought to change how consumers receive care.

Spurred by nationwide stay-at-home orders and heightened health safety, we saw consumer preferences drastically change as more and more patients opted to receive prescriptions and care directly at home. Almost two years and an in-flux of direct-to-consumer (D2C) platforms later, this shift in preferences has remained the same.

This shift has not only created new ways for providers to reach patients where they are (their homes), but it has...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Patient / Consumer, Pharma, Pharma / Biotech, Technology, Telehealth
A Better Connected Care Journey
Venture-backed telemental health care companies are creating a new opioid epidemic
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
The Forming of the Global Service Providers Market for Digital Health Companies
Increased Skilled Nursing Facility Spending Tied to Health Systems’ Higher Telemedicine Use

Share This Article